Activating mutations of BRAF lead to consecutive downstream activation of the RAS–MEK–MAPK signaling cascade, promoting cell proliferation, and survival while inhibiting apoptosis, and driving tumor growth (16). Here, MAP2K7 is linked to neoplasm.